BioNTech Investor Day Presentation Deck

A solution optimized for quality, speed and sustainability ✓Quality Speed Sustainability Proven efficacy and safety of mRNA GMP-compliant facility and processes Multiple quality controls to release vaccine batches Turnkey facility to shorten set-up time Replicable transfer of processes Training and 24/7 support BIONTECH mRNA is a new drug class suitable for many diseases Adaptation for future needs through modular facility design Decentralized process updates and continuous improvement 00

View entire presentation